Current highlights

  1. Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist

    Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist

    Abstract Full Text Full Text PDF (1,9 MB)
  2. Superior Quality of Life and Improved Surgical Margins Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve: A Prospective Single-surgeon Study of 1552 Consecutive Cases eulogo1

    Superior Quality of Life and Improved Surgical Margins Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve: A Prospective Single-surgeon Study of 1552 Consecutive Cases

    Abstract Full Text Full Text PDF (1,1 MB)
  3. Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer eulogo1

    Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer

    Abstract Full Text Full Text PDF (504 KB)
  4. Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study (REACTT) eulogo1

    Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study (REACTT)

    Abstract Full Text Full Text PDF (1,7 MB)
  5. Impact of Adjuvant Radiation Therapy on Urinary Continence Recovery After Radical Prostatectomy

    Impact of Adjuvant Radiation Therapy on Urinary Continence Recovery After Radical Prostatectomy

    Abstract Full Text Full Text PDF (336 KB)

Hot off the press

  1. Differences in Treatment and Outcome After Treatment with Curative Intent in the Screening and Control Arms of the ERSPC Rotterdam

    Differences in Treatment and Outcome After Treatment with Curative Intent in the Screening and Control Arms of the ERSPC Rotterdam

    Abstract Full Text Full Text PDF (597 KB) Patient Summary
    Corrected
  2. A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)

    A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)

    Abstract Full Text Full Text PDF (722 KB) Patient Summary
    Corrected
  3. International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality

    International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality

    Abstract Full Text Full Text PDF (15,0 MB) Patient Summary
    Corrected
  4. A Randomised Phase 2 Trial of Dexamethasone Versus Prednisolone in Castration-resistant Prostate Cancer

    A Randomised Phase 2 Trial of Dexamethasone Versus Prednisolone in Castration-resistant Prostate Cancer

    Abstract Full Text Full Text PDF (1,0 MB) Patient Summary
    Corrected
  5. Validation and Reliability Testing of the EORTC QLQ-NMIBC24 Questionnaire Module to Assess Patient-reported Outcomes in Non–Muscle-invasive Bladder Cancer

    Validation and Reliability Testing of the EORTC QLQ-NMIBC24 Questionnaire Module to Assess Patient-reported Outcomes in Non–Muscle-invasive Bladder Cancer

    Abstract Full Text Full Text PDF (401 KB)
    Corrected

Latest news

  1. October Reviewer of the Month - Dr. Fumitaka Koga

    28 Sep 2014

    Fumitaka Koga is currently the chief urologist at Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. He ...

    October Reviewer of the Month - Dr. Fumitaka Koga

  2. New Associate Editor- Dr. Stephen Boorjian

    2 Sep 2014

    European Urology and The European Association of Urology are pleased to welcome Dr. Stephen Boorjian to the Editorial team in the position of ...

    New Associate Editor-  Dr. Stephen Boorjian

  3. Recognizing the 2013 Impact Factor Contributors

    31 Jul 2014

    ​Editor in Chief Prof. James Catto would like to extend his thanks to our Authors, Reviewers, Readers and Editors who have once again helped put ...

    Recognizing the 2013 Impact Factor Contributors

More news